Z9V-72297-10547
4 vaccinations
1 coded response
49 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 490 / MI
- Registered
- 2021-03-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-04
Registered in v-safe
-
2021-03-04
Dose 1 — Pfizer-BioNTech
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-18
-
2021-03-24
Dose 2 — Pfizer-BioNTech
- 2021-03-24
-
2021-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-26
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: Good · Site: Pain · Headache, Muscle or body achesFree text: Loss of appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-27
- 2021-04-07
- 2021-04-14
- 2021-04-21
- 2021-04-28
- 2021-05-07
- 2021-06-24
- 2021-09-22
-
2021-11-20
Dose 3 — Pfizer-BioNTech
-
2021-11-21
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-22
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-11-23
- 2021-11-24
- 2021-11-25
- 2021-11-26
- 2021-11-27
- 2021-12-04
- 2021-12-11
- 2021-12-18
- 2021-12-25
- 2022-01-01
- 2022-02-19
- 2022-05-21
-
2022-11-19
Dose 4 — Pfizer-BioNTech
-
2022-11-19
Health check-in — day 0, dose 4Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-11-20
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
- 2022-11-21
- 2022-11-22
- 2022-11-23
- 2022-11-24
- 2022-11-25
- 2022-11-26
- 2022-12-03
- 2022-12-10
- 2022-12-17
- 2022-12-24
- 2022-12-31
- 2023-02-18
- 2023-05-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | |
| 2 | 2021-03-24 | Pfizer-BioNTech | |
| 3 | 2021-11-20 | Pfizer-BioNTech | No |
| 4 | 2022-11-19 | Pfizer-BioNTech | No |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Loss of appetite
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release